Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ATHROMBIN-K

WARFARIN POTASSIUM

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ATHROMBIN-K is listed in Drugs@FDA under application 011771 (NDA).

Marketing status: Discontinued Active ingredient WARFARIN POTASSIUM Form and strength TABLET;ORAL - 10MG Sponsor PHARM RES ASSOC Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ATHROMBIN-K is listed in Drugs@FDA under application 011771 (NDA). Marketing status: Discontinued Active ingredient WARFARIN POTASSIUM Form and strength TABLET;ORAL - 10MG Sponsor PHARM RES ASSOC Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.